Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Palmoplantar keratoderma, Nagashima type"
Page 1
Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.
Liu J, Chen Z, Hu L, Song Z, Mo R, Tsang LS, Liu Y, Huang X, Gong Z, Lin Z, Yang Y. Liu J, et al. J Dermatol. 2023 Mar;50(3):375-382. doi: 10.1111/1346-8138.16621. Epub 2022 Nov 1. J Dermatol. 2023. PMID: 36317385
Nagashima-type palmoplantar keratoderma (NPPK) is the most prevalent hereditary palmoplantar keratoderma (PPK) in China, but there is a paucity of epidemiological data on the Chinese population. ...Identification of new mutations are impo …
Nagashima-type palmoplantar keratoderma (NPPK) is the most prevalent hereditary palmoplantar keratoder …
Effect of Gentamicin Ointment in Patients with Nagashima-type Palmoplantar Keratosis: A Double-blind Vehicle-controlled Study.
Li Y, Yu X, Pan C, Wang Y, Han J, Yao Z, Li M. Li Y, et al. Acta Derm Venereol. 2021 Feb 11;101(2):adv00392. doi: 10.2340/00015555-3760. Acta Derm Venereol. 2021. PMID: 33554268 Free PMC article. Clinical Trial.
Gentamicin ointment has potential in the treatment of Nagashima-type palmoplantar keratosis. However, there is a lack of reliable study data. ...In conclusion, gentamicin ointment demonstrated positive responses and good tolerance in treating Nagashima …
Gentamicin ointment has potential in the treatment of Nagashima-type palmoplantar keratosis. However, there is a lack o …
Acral peeling in Nagashima type palmo-plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion.
Cohen-Barak E, Azzam W, Koetsier JL, Danial-Farran N, Barcan M, Hriesh M, Khayat M, Edison N, Krausz J, Gafni-Amsalem C, Kubo A, Godsel LM, Ziv M, Allon-Shalev S. Cohen-Barak E, et al. Exp Dermatol. 2022 Feb;31(2):214-222. doi: 10.1111/exd.14444. Epub 2021 Aug 17. Exp Dermatol. 2022. PMID: 34379845 Free PMC article.
A subset of APSS is caused by mutations in protease inhibitor encoding genes, resulting in unopposed protease activity and desmosomal degradation and/or mis-localization, leading to enhanced epidermal desquamation. We investigated two Arab-Muslim siblings with mild keratoderma …
A subset of APSS is caused by mutations in protease inhibitor encoding genes, resulting in unopposed protease activity and desmosomal degrad …
A novel SERPINA12 variant and first European patients with diffuse palmoplantar keratoderma.
Brandt E, Harjama L, Elomaa O, Saarela J, Donner K, Lappalainen K, Kivirikko S, Ranki A, Kere J, Kettunen K, Hannula-Jouppi K. Brandt E, et al. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):413-418. doi: 10.1111/jdv.19498. Epub 2023 Sep 22. J Eur Acad Dermatol Venereol. 2024. PMID: 37684051
BACKGROUND: Hereditary palmoplantar keratodermas (hPPKs) comprise a heterogeneous group of skin disorders characterized by persistent palmoplantar hyperkeratosis. ...The disorder appears to share similarities with another hPPK associated with protease overactivity, …
BACKGROUND: Hereditary palmoplantar keratodermas (hPPKs) comprise a heterogeneous group of skin disorders characterized by persistent …